XOMA — Xoma Royalty Share News
0.000.00%
Last trade - 00:00- $792.01m
- $808.75m
- $52.15m
BiotechBroyalty aggregator XOMA reports Q3 net income of $14.1 mln
Brief: XOMA Q3 EPS USD 0.7
Brief: Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase Agreement
Brief: Xoma Royalty Says May Offer And Sell Shares Of Common Stock Of Up To $75 Million - SEC Filing
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: XOMA Royalty Announces Closing Of Tender Offer For HilleVax
Xoma Royalty Corp Reports Results For The Quarter Ended June 30: Earnings Summary
Brief: XOMA Q2 EPS USD 0.44
Xoma Royalty Corp Expected To Post A Loss Of 22 Cents A Share: Earnings Preview
Brief: Hillevax Enters Into A Definitive Agreement To Be Acquired By Xoma Royalty For $1.95 In Cash Per Share Plus A Contingent Value Right
Brief: XOMA Royalty to acquire LAVA Therapeutics for $1.16-$1.24 per share
Brief: ESSA Pharma Inc. Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction
Brief: Turnstone Biologics to Be Acquired by XOMA for $0.34/Share Plus Contingent Value Right
Xoma Royalty Corp Reports Results For The Quarter Ended March 31: Earnings Summary
Xoma Royalty Corp Expected To Post A Loss Of 30 Cents A Share: Earnings Preview
Brief: Xoma Royalty Completes Sale Of Kinnate Pipeline Assets
Xoma Royalty Corp Reports Results For The Quarter Ended December 31: Earnings Summary
Xoma Royalty Corp Expected To Post A Loss Of 30 Cents A Share: Earnings Preview